Sector › Medicine

Press Releases

Beat The Silent Disease of Osteoporosis with LAC, Before It's Too Late!

Nov 18, 2024 13:00 HKT/SGT

Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment)

Nov 15, 2024 16:33 HKT/SGT

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease

Nov 15, 2024 13:31 HKT/SGT

Resorttrust Group and Mitsubishi Corporation Launch Joint Study in Medical Tourism

Nov 15, 2024 11:32 HKT/SGT

ニュートンバイオキャピタル、⽇本の創薬スタートアップのテンセグリティファーマに対し、第 2 号ファンドより、⽇本初の投資を発表

Nov 14, 2024 11:00 JST

Femto Technologies Announces Third Quarter 2024 Financial Results

Nov 14, 2024 07:00 HKT/SGT

Predictive Heart Monitoring Startup, GPx, Secures New Investment From NEC X; Joins Elev X! Boost Venture Studio Program

Nov 13, 2024 11:05 HKT/SGT

Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024

Nov 08, 2024 09:31 HKT/SGT

NEC and NEC Bio publish foundational work on T Cell Receptor engineering using proprietary generative AI at the Society for Immunotherapy of Cancer annual meeting

Nov 07, 2024 10:40 HKT/SGT

Eisai's Corporate Venture Capital Subsidiary, Eisai Innovation, Inc., Selected for AMED's 'Strengthening Program for Pharmaceutical Startup Ecosystem"

Nov 05, 2024 10:35 HKT/SGT

JBM Healthcare Issues Positive Profit Alert

Nov 04, 2024 15:00 HKT/SGT

健倍苗苗發佈盈喜預期股東應佔綜合溢利增加不少於50%

Nov 01, 2024 13:04 HKT/SGT

健倍苗苗发布盈喜预期股东应占综合溢利增加不少于50%

Nov 01, 2024 12:56 HKT/SGT

Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status

Nov 01, 2024 12:56 HKT/SGT

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer's Disease (CTAD) Conference

Oct 31, 2024 12:56 HKT/SGT

Eisai Presents Latest Clinical Findings Suggesting Inhibition of Tau Propagation by Anti-MTBR Tau Antibody E2814 at the 17th Clinical Trials on Alzheimer's Disease Conference (CTAD)

Oct 31, 2024 10:33 HKT/SGT

Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio

Oct 29, 2024 20:16 HKT/SGT

TOPVISION Transfers From LEAP Market To ACE Market, Signs Underwriting Agreement With Hong Leong Investment Bank

Oct 29, 2024 17:30 HKT/SGT

Machine learning can predict the mechanical properties of polymers

Oct 26, 2024 23:08 JST

Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award'

Oct 25, 2024 09:18 HKT/SGT